Business
Trading Update & Management Appointments
Trading Update & Management Appointments.
About this update from Cambridge Nutritional Sciences Plc
[{"type":"text","content":"\n \nRNS Number : 7075E Omega Diagnostics Group PLC 12 April 2011 \n \n\n \nOmega Diagnostics Group PLC\n(\"Omega\" or \"the Company\")\n \nTrading Update and Management Appointments\n \nOmega, the AIM listed medical diagnostics company, announces that revenue for the year ended 31 March 2011 is expected to be £7.9m, approximately 27% ahead of last year's result (31 March 2010: £6.2m). On a like-for-like basis, excluding the acquisition of Allergopharma's IVD business, sales growth is approximately 12%. Profit before tax (and before acquisition costs, share based payments, IFRS-related discount unwinds and amortisation of intangible assets) is expected to be in line with market expectations\n \nOmega has seen growth in most of its key product groups with another year of success particularly in its food intolerance business. \n \n 31 March 2011 31 March 2010 % increase \n \nFood intolerance £3.58m £2.96m + 21% \nInfectious disease £1.98m £1.79m + 11%\nAutoimmune disease £0.57m £0.66m &nb...